5//SEC Filing
Mayersohn Joel David 5
Accession 0001493152-21-003961
CIK 0001310527other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:00 PM ET
Size
10.3 KB
Accession
0001493152-21-003961
Insider Transaction Report
Form 5
Mayersohn Joel David
Director
Transactions
- Award
Options to buy common stock
2020-01-06+40,000→ 40,000 totalExercise: $0.50From: 2020-01-06Exp: 2030-01-06→ COMMON STOCK (40,000 underlying) - Conversion
COMMON STOCK
2020-09-30$0.22/sh+331,834$73,003→ 371,594 total - Award
COMMON STOCK
2020-12-17$0.22/sh+96,782$21,292→ 468,376 total
Holdings
- 37,840
Options to buy common stock
Exercise: $0.50From: 2018-12-01Exp: 2028-12-01→ COMMON STOCK (37,840 underlying)
Footnotes (2)
- [F1]Shares acquired upon conversion of promissory note at a conversion price of $0.22 per share.
- [F2]Shares acquired upon conversion of accured directors fees at a conversion price of $0.22 per share.
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001588395
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:00 PM ET
- Size
- 10.3 KB